scholarly journals Ezh2 is essential for the generation of functional yolk sac derived erythro-myeloid progenitors

2021 ◽  
Vol 12 (1) ◽  
Author(s):  
Wen Hao Neo ◽  
Yiran Meng ◽  
Alba Rodriguez-Meira ◽  
Muhammad Z. H. Fadlullah ◽  
Christopher A. G. Booth ◽  
...  

AbstractYolk sac (YS) hematopoiesis is critical for the survival of the embryo and a major source of tissue-resident macrophages that persist into adulthood. Yet, the transcriptional and epigenetic regulation of YS hematopoiesis remains poorly characterized. Here we report that the epigenetic regulator Ezh2 is essential for YS hematopoiesis but dispensable for subsequent aorta–gonad–mesonephros (AGM) blood development. Loss of EZH2 activity in hemogenic endothelium (HE) leads to the generation of phenotypically intact but functionally deficient erythro-myeloid progenitors (EMPs), while the generation of primitive erythroid cells is not affected. EZH2 activity is critical for the generation of functional EMPs at the onset of the endothelial-to-hematopoietic transition but subsequently dispensable. We identify a lack of Wnt signaling downregulation as the primary reason for the production of non-functional EMPs. Together, our findings demonstrate a critical and stage-specific role of Ezh2 in modulating Wnt signaling during the generation of EMPs from YS HE.

Blood ◽  
2011 ◽  
Vol 118 (21) ◽  
pp. 910-910
Author(s):  
Kathleen E McGrath ◽  
Katherine H Fegan ◽  
Jenna M Frame ◽  
Paul D Kingsley ◽  
James Palis

Abstract Abstract 910 In the mammalian embryo, hematopoietic stem cells (HSC) emerge from vascular beds and colonize the fetal liver. The first HSC are found in the murine fetal liver by embryonic day 12.5 (E12.5). However blood function is required before HSC have formed, and two earlier waves of hematopoietic potential arise to sustain the embryo. The first wave of hematopoietic progenitors are formed in the yolk sac between E7.25 and E8.5 and are termed “primitive” because, along with megakaryocyte and macrophage potential, they differentiate into primitive erythroid cells that mature in the circulation and express embryonic globins. A second lineage of hematopoietic potential has been characterized in the murine and human yolk sac as well as in zebrafish. These cells have been termed “EMP”, erythro-myeloid progenitors, that generate definitive erythroid and myeloid lineages, including granulocytes. We find that EMP emerging in the mouse embryo express many of the markers associated with HSC emergence from hemogenic endothelium. At early stages of their emergence (E8.5), EMP express not only kit and CD41, but also VE-cadherin, CD31 and CD34. A day later, EMP constitute a robust population of over 1,000 cells in the yolk sac and display diminished expression of VE-cadherin and increased expression of CD45. However, unlike HSC, EMP do not express Sca1, but do express the myeloid progenitor marker CD16/32 (low affinity FCgamma receptor II/III). Like CD45, CD16/32 is expressed on a subset of the CD41+/kit+ cells at E8.5. Colony forming assays confirm that EMP potential is found in both CD16/32 positive and negative CD41+/kit+ cells. By E9.5, over 90% of CD41+/kit+ cells also express CD16/32 and all of the hematopoietic colony-forming potential at E9.5 is found in this triple-positive population. The transition from endothelial-associated to hematopoietic-associated genes suggests that EMP may emerge from hemogenic endothelial intermediates. Between E9.5 and E11.5, cells with the EMP immunophenotype are found in the bloodstream and become concentrated in the liver, where evidence of very robust erythro-myeloid differentiation precedes HSC colonization. In culture, EMP rapidly expand, dividing twice daily, and within 6 days generate predominately erythroid cells as well as smaller numbers of megakaryocyte, macrophage and mast cells, but only rare granulocytes. This is in contrast to lin-/kit+ ScaI- bone marrow progenitors grown in the same culture conditions that generate predominately myeloid cells, particularly granulocytes, and rarely mast cells. In agreement with data in the zebrafish, we also do not see evidence of lymphoid potential or RAG2 expression in EMP cultures or expression of the lymphoid markers Flt3 and IL7 receptor on the cell surface of EMP. In order to better understand the lineage potential of EMP, we examined the expression of known transcriptional regulators of bone marrow hematopoiesis. In the adult, relative levels of GATA1 versus Pu.1 are proposed to determine fate between megakaryocyte/erythroid progenitors (MEP- GATA1 hi) and granulocyte/macrophage progenitors (GMP-Pu.1 hi). Consistent with their erythro-myeloid potential, EMP expressed both GATA1 and Pu.1 at intermediate levels compared to adult marrow-derived MEP and GMP. In the adult, Gfi-1 and C/EBPalpha are both proposed to upregulate granulocyte versus macrophage differentiation. We found lower levels of these regulators in EMP compared to GMP, consistent with EMP cultures generating small numbers of granulocytes versus macrophages. In addition, the GATA1 expression within the Pu.1+ GMP is found to increase mast cell potential and, thus, the high GATA1 and Pu.1 expression in EMP may account for their high mast cell potential. Taken together, these data suggest that, like HSC, EMP emerge from hemogenic endothelium and their erythro-myeloid potential is governed by the action of shared regulatory networks. However, the transcription factors and markers are present in the EMP in unique combinations consistent with their specific role in providing a transient initial wave of definitive hematopoiesis in the embryo. Disclosures: No relevant conflicts of interest to declare.


2019 ◽  
Vol 14 (7) ◽  
pp. 598-606
Author(s):  
Sarah Albogami

Background:: Regeneration is the process by which body parts lost as a result of injury are replaced, as observed in certain animal species. The root of regenerative differences between organisms is still not very well understood; if regeneration merely recycles developmental pathways in the adult form, why can some animals regrow organs whereas others cannot? In the regulation of the regeneration process as well as other biological phenomena, epigenetics plays an essential role. Objective:: This review aims to demonstrate the role of epigenetic regulators in determining regenerative capacity. Results:: In this review, we discuss the basis of regenerative differences between organisms. In addition, we present the current knowledge on the role of epigenetic regulation in regeneration, including DNA methylation, histone modification, lysine methylation, lysine methyltransferases, and the SET1 family. Conclusion:: An improved understanding of the regeneration process and the epigenetic regulation thereof through the study of regeneration in highly regenerative species will help in the field of regenerative medicine in future.


Blood ◽  
2008 ◽  
Vol 112 (11) ◽  
pp. 529-529
Author(s):  
Brigham B Hyde ◽  
Alvaro A Elorza ◽  
Hanna K Mikkola ◽  
Thorsten M Schlaeger ◽  
Orian S Shirihai

Abstract We previously described that mitochondrial ATP-Binding Cassette transporter, ABCme (ABCB10) is induced by GATA-1 in erythroid cells and that its over-expression leads to increased heme production. However, the role of ABCme in vivo and the hematologic phenotype of its deficiency have not been described thus far. Here we report for the first time that ABCme is essential for embryonic blood development in vivo. ABCme deficient mouse was generated on 129SvEvBrd/C57BL6J background and backcrossed to n = 4 on the C57BL6J. The homozygous KO mouse is embryonic lethal. ABCme KO dies at 12.5 days of gestation and displayed aplastic embryonic anemia by 10.5 days of gestation, manifested as improper blood development as well as erythroid progenitor apoptosis (Figure 1). Ex vivo analysis of maturation of isolated yolk sac blood determined that ABCme KO erythroid cells fail to differentiate beyond the stage of basophilic erythroblast and exhibit 55% of apoptosis in CD71 positive cells in comparison with 29.25% in ABCme HET, and 17.5% in WT. Erythroid colony assay indicated 50% reduction in the formation of CFU-E and an 80% reduction in BFU-E in comparison with WT. Disruption of heme synthesis may result in accumulation of heme intermediates that are pro-oxidants. To test the hypothesis that apoptosis is induced by oxidative damage we tested both mitochondrial oxidation and the rescue effects of mitochondrial antioxidants in the ABCme KO. Isolated mitochondria of ABCme KO erythroid cells demonstrated significantly elevated levels (5 fold) of oxidized protein in comparison to both WT and HET cells. This elevated level of superoxide were confirmed and identified to be mitochondrial in nature by FACS analysis of superoxide sensitive dye MitoSox. Using antioxidants we tested the patho-physiological role of the elevated ROS in the hematologic phenotype. Treatment of ABCme KO cells with the SOD2 mimetic TBAP resulted in partial and complete rescue of the apoptotic phenotypes of the KO and the HET respectively. Our findings suggest that ABCme is required for erythroid development in vivo and that its deficiency results in impaired erythroid maturation, hemoglobinzation, and increased mitochondrial oxidative damage. Figure SEQ Figure \* ARABIC 1: Impaired Blood Development of ABCme deficient embryos Figure. SEQ Figure \* ARABIC 1: Impaired Blood Development of ABCme deficient embryos Light microscopy of Day 10.5 p.c. Embryo and Yolk Sac (Top). At this stage KO embryos are still alive as denoted by heartbeat as well as normal development of other organ systems. However, lack of red cell development is apparent. H/E staining of day 10.5 p.c. yolk sac blood islands (Bottom). KO blood islands demonstrate reduced number, increased nuclear fragmentation associated with apoptosis, and a lack of developed erythroid progenitors. (WT= Wildtype mice, KO= ABCme −/− mice.)


2021 ◽  
Author(s):  
Yang Chai ◽  
Tingwei Guo ◽  
Xia Han ◽  
Jinzhi He ◽  
Jifan Feng ◽  
...  

Epigenetic regulation plays extensive roles in diseases and development. Disruption of epigenetic regulation not only increases the risk of cancer, but can also cause various developmental defects. However, it is still unclear how epigenetic regulators coordinate with tissue-specific regulatory factors during morphogenesis of specific organs. Using palatogenesis as a model, we reveal the functional significance of Kdm6b, a H3K27me3 demethylase, in regulating embryonic development. Our study shows that Kdm6b plays an essential role in neural crest development, and loss of Kdm6b disturbs p53 pathway-mediated activity, leading to complete cleft palate along with cell proliferation and differentiation defects. Furthermore, activity of H3K27me3 on the promoter of p53 is precisely controlled by Kdm6b, and Ezh2 in regulating p53 expression in cranial neural crest cells. More importantly, Kdm6b renders chromatin accessible to the transcription factor Tfdp1, which binds to the promoter of p53 along with Kdm6b to specifically activate p53 expression during palatogenesis. Collectively our results highlight the important role of the epigenetic regulator Kdm6b and how it cooperates with Tfdp1 to achieve its functional specificity in regulating p53 expression, and further provide mechanistic insights into the epigenetic regulatory network during organogenesis.


2020 ◽  
Author(s):  
Mayur Bansal ◽  
Danila Cuomo ◽  
Ephraim A. Yusi ◽  
Rachel M. Lynch ◽  
David Threadgill

Abstract BackgroundBeta-catenin (CTNNB1) is a key downstream effector of the WNT signaling pathway that is involved in embryonic development and tumorigenesis. To further study the role of CTNNB1 in gut tumorigenesis, mice carrying a conditional, stabilizing mutation of Ctnnb1 (Ctnnb1tm1Mmt) were crossed with mice expressing CRE recombinase under the intestinal epithelial Villin 1 promoter (Vil1-Cre).ResultsContrary to expectations, no double heterozygous mice (Ctnnb1tm1Mmt, Vil1-Cre) were observed at birth, suggesting embryonic lethality. After assessment of the timing of embryonic lethality, which occurs between embryonic stage 11.5 and 13.5, the (ROSA)26Sortm1Sor reporter was crossed with Vil1-Cre and the resulting embryos and placentae were stained for beta-galactosidase activity. CRE under control of the Vil1 promoter was found to be expressed in the yolk sac epithelium, indicating potential extraembryonic defects caused by constitutive WNT signaling. Analysis of RNAseq data from yolk sac-derived RNA indicated changes in inflammation-associated pathways due to the constitutive WNT signaling. ConclusionsEmbryonic lethality due to Vil1-Cre driven WNT signaling in the yolk sac epithelium causes potential defects in the transfer of yolk sac derived erythromyeloid progenitor cells and hematopoietic stem cells to the embryo, and shows the limits of using the Vil1-Cre transgenic line for analysis of adult tissues.


Blood ◽  
2014 ◽  
Vol 124 (21) ◽  
pp. 768-768
Author(s):  
Jenna M. Frame ◽  
Kathleen E McGrath ◽  
Katherine H. Fegan ◽  
James Palis

Abstract Hematopoietic stem cells (HSCs) emerge from arterial vessels of the mouse embryo through a Runx1-dependent process of endothelial-to-hematopoietic transition beginning at embryonic day 10.5 (E10.5). This arterial endothelial-to-hematopoietic transition is known to require embryonic circulation as well as beta-catenin signaling within the endothelial precursor, known as hemogenic endothelium. However, embryonic survival is dependent on the earlier emergence of a robust wave of yolk sac-derived definitive erythro-myeloid progenitors (EMPs), which have unilineage as well as multilineage potential, including high-proliferative potential colony forming cell (HPP-CFC) potential (Palis et al., PNAS, 2001). Like HSCs, EMP specification is dependent on Runx1, suggesting that they also emerge from a hemogenic endothelial precursor. However, the spatial localization of EMPs in the yolk sac and the mechanisms governing their emergence are not well understood. To visualize emerging EMPs in the yolk sac, we performed whole-mount immunohistochemistry for Kit, which we have demonstrated to contain nearly all EMP potential at E9.5. Kit+ cells coexpress Runx1 and CD31, and a subset have a polygonal/endothelial morphology, appear integrated into the vascular network, and are associated with rounded Kit+ cells in clusters, features consistent with an endothelial-to-hematopoietic transition. However, unlike HSCs, which emerge from major embryonic arteries, clusters of EMPs are located in larger and smaller caliber vessels in branches of both the arterial and venous vasculature, which is spatially organized within the yolk sac. To determine if EMP emergence from the vasculature is dependent on embryonic blood flow, which is required for HSC emergence, we analyzed the yolk sacs of Ncx1-null embryos, which fail to initiate heart contractions and subsequently lack embryonic circulation. Despite the lack of vascular remodeling in these circulation-deficient yolk sacs, Ncx1-null EMPs displayed normal cluster morphology, including both polygonal and rounded kit+ cells, indicating the endothelial-to-hematopoietic transition can occur without the mechanical influence of blood flow. To address whether EMP formation is responsive to other developmental signals, we utilized a yolk sac explant culture to evaluate the propensity of hemogenic endothelial cells to commit to hematopoiesis ex vivo. Culture of intact E8.5 yolk sacs for 48 hours with the canonical Wnt ligand Wnt3a resulted in an increase in both day 6-7 colony forming cells and day 13-14 HPP-CFC when compared with control yolk sacs. Preliminary treatment with Dkk1 alone did not adversely affect colony-forming activity when compared with untreated yolk sacs, and potentiation of endogenous canonical Wnt signaling with HLY78 did not augment colony production, suggesting that low levels of endogenous Wnt ligands are produced ex vivo. Despite the positive effect of Wnt3a on whole yolk sacs, treatment of isolated E9.5 Kit+CD41+CD16/32+ EMPs with Wnt3a did not increase colony formation, suggesting that Wnt signaling augments progenitor production at, or prior to, the hemogenic endothelial stage. Preliminary results utilizing imaging flow cytometry demonstrated increased beta-catenin intensity within the nuclear region in E9.5 Kit+VE-Cadherin/AA4.1+ endothelium following Wnt3a treatment, suggesting that hemogenic endothelial cells in the yolk sac are Wnt responsive. Consistent with this finding, in vitro Wnt3a treatment on primary E8.5-9.5 VE-Cadherin/AA4.1+CD16/32- endothelial cells resulted in upregulation of the beta-catenin target gene Axin2. To address whether Wnt signaling is endogenously active in vivo, we analyzed E8.5-E9 yolk sacs of BAT-gal reporter mice (Maretto et al., PNAS, 2003), and visualized a subset of cells with endothelial morphology expressing LacZ. Taken together, these data support the concept that EMPs, like HSCs, emerge from hemogenic endothelium. Surprisingly, this earlier endothelial-to-hematopoietic transition in the yolk sac is not dependent on blood flow or an arterial identity. However, similar to HSC emergence, EMP emergence from hemogenic endothelium is positively regulated by canonical Wnt signaling. These data highlight the presence of spatially, temporally, and functionally heterogeneous populations of hemogenic endothelium in the mammalian conceptus. Disclosures No relevant conflicts of interest to declare.


Author(s):  
Robert Pfaller

Starting from a passage from Slavoj Žižek`s brilliant book The Sublime Object of Ideology, the very passage on canned laughter that gave such precious support for the development of the theory of interpassivity, this chapter examines a question that has proved indispensable for the study of interpassivity: namely, what does it mean for a theory to proceed by examples? What is the specific role of the example in certain example-friendly theories, for example in Žižek’s philosophy?


2016 ◽  
Author(s):  
Ann-Kristin Picke ◽  
Lykke Sylow ◽  
Lisbeth L V Moller ◽  
Rasmus Kjobsted ◽  
Erik Richter ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document